Laplace Interventional

Industry
Medical Devices
Founded Year
2020
Headquarters
Plymouth, Minnesota
Employee Count
10

Key People

Assessment

Team
Aspect: First-time 10+ yrs
Summary: The leadership team comprises first-time entrepreneurs with over a decade of experience in the medical device industry.

The leadership's deep understanding of the medical device sector, combined with their entrepreneurial drive, suggests a strong foundation for the company's growth and innovation.

Clinical Need
Aspect: Very Strong
Summary: There is a significant unmet clinical need for minimally invasive tricuspid valve interventions.

The prevalence of tricuspid regurgitation and the limitations of current treatments underscore the demand for innovative solutions like those offered by Laplace Interventional.

Competition
Aspect: Very crowded + Strategics
Summary: The market features established players and strategic entrants.

With major companies like Edwards Lifesciences and Abbott already in the space, differentiating and capturing market share will require significant effort and innovation.

Technical Challenge
Aspect: Complex
Summary: Developing transcatheter tricuspid valve technology involves significant technical complexities.

The intricate nature of tricuspid valve anatomy and the need for precise device deployment present substantial engineering challenges.

Patent
Aspect: Applied
Summary: The company has applied for patents but lacks granted ones.

While patent applications suggest a commitment to proprietary technology, the absence of granted patents may expose the company to competitive risks.

Financing
Aspect: Medium
Summary: The company has secured moderate funding from investors.

While initial investments provide a foundation, scaling operations and navigating regulatory pathways will likely require further capital infusion.

Regulatory
Aspect: Running FIH
Summary: The company is conducting first-in-human trials.

Initiating first-in-human trials demonstrates advancement in product development and a commitment to meeting regulatory standards.

Opportunity Rollup

Odds of Success
3.55
Peak Market Share
4.6
Segment CAGR
15.1%
Market Segment
Transcatheter Tricuspid Valve Interventions
Market Sub Segment
Transcatheter Tricuspid Valve Replacement
Year Post Launch Market Penetration (%)
1 0.23
2 0.69
3 1.61
4 3.22
5 4.60

Key Takeaway

Laplace Interventional addresses a significant clinical need with innovative technology but faces challenges in a competitive and complex market.